Global Innovative Platforms Inc. (GIPL): Operating Income

Annual figures by period end, from SEC filings.

-$718.3K
Year ended 2025-09-30
-$677.0K
Trailing 12 months to 2026-06-30
2021-09-30: -$73.3K2022-09-30: -$53.8K2023-09-30: -$282.8K2024-09-30: -$136.2K2025-09-30: -$718.3K-$718.3K
2021-09-30 Operating Income (USD) 2025-09-30
Period endedOperating IncomeChange YoYSource filing
2025-09-30-$718.3Kn/m2026-01-13, From 2024-10-01
2024-09-30-$136.2Kn/m2026-01-13, From 2023-10-01
2023-09-30-$282.8Kn/m2024-12-30, From 2022-10-01
2022-09-30-$53.8Kn/m2024-08-23, From 2021-10-01
2021-09-30-$73.3Kn/a2023-03-10, From 2020-10-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Global Innovative Platforms Inc. (GIPL)2025-09-30-$718.3Kn/m
Baxter International Inc (BAX)2025-12-31-$308.00Mn/m
Becton Dickinson & Co (BDX)2025-09-30$2.58B+7.6%
3M Co (MMM)2025-12-31$4.63B-4.0%
Teleflex Inc (TFX)2025-12-31$118.37M+14.2%
West Pharmaceutical Services Inc (WST)2025-12-31$584.90M+2.6%
Stryker Corp (SYK)2025-12-31$4.89B+32.5%
Haemonetics Corp (HAE)2026-03-28$156.73M-29.3%
KORU Medical Systems, Inc. (KRMD)2025-12-31-$2.97Mn/m

Compare GIPL, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗